Proteomics and AI bring earlier risk prediction into sharper focus
From Alzheimer’s risk to cardiovascular prediction, this review shows how protein profiling and AI could help detect disease…
AI-powered chemistry accelerates discovery of selective cancer inhibitors
Recently, the Insilico team’s research entitled “An Internal Sulfur-Lone Pair Interaction Enabled the Discovery of Potential and Sub-Family…
OICR funds four Ontario teams to develop next-generation cancer therapies
Better cancer care depends on better treatment options. That’s why the Ontario Institute for Cancer Research (OICR) is…
New opioid painkiller has surprisingly few side effects
Structure of N-desethyl-fluornitrazene, or DFNZ. Using a long-abandoned class of opioids as their starting point, scientists have…
Bacterial cell fate under stress: lipid remodeling and antimicrobial peptide attack
Devi, N. S. et al. Overview of antimicrobial resistance and mechanisms: The relative status of the past and…
A new global collaboration to expand patient-derived stem cell models and accelerate treatments
A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery – current…
Purdue University accelerates rare disease drug discovery with the WELLJET dispenser stacker
Scientists at Purdue University are using the WELLJET dispenser stacker from INTEGRA Biosciences to increase the speed, consistency…
Quantum Computing Built An Impossible Molecule — With Big Implications
Isosurface of the Dyson orbital, taken from Piccinelli, Samuele, et al., “Exploring pathways towards quantum advantage in quantum…
Optibrium introduces graphical interface for QuanSA to enhance ligand-based affinity predictions
Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA™ plugin…
Boosting mass spec’s sensitivity and throughput with parallelization
Mass spectrometry unveils a world of proteins, from those in cells to fragments found on fossils, as…
Study uncovers how tuberculosis bacteria fuel themselves during infection
Researchers at The Hospital for Sick Children (SickKids) have uncovered how the bacteria that causes tuberculosis fuels itself during infection, providing new insights…
Pharma’s AI Investment Signals New Drug Discovery Paradigm
From improved molecular design to AI-driven automation, waves of AI tools promise to accelerate therapeutic development. Still, skeptics…